VIDEO: Faricimab dosing interval may extend up to 20 weeks in wet AMD, DME

WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, Michael A. Singer, MD, presents data on dosing intervals for faricimab as a treatment for wet age-related macular degeneration and diabetic macular edema.
“Over 50% of people in both wet AMD and DME who were currently in the 16-week arm didn’t really need a shot based on disease rescue criteria, and they could go to 20 weeks,” he said.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.